These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3096792)

  • 1. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.
    Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J
    Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovulation induction with pulsatile luteinizing hormone-releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: endocrine results.
    Burger CW; Hompes PG; Korsen TJ; Schoemaker J
    Fertil Steril; 1989 Jan; 51(1):20-9. PubMed ID: 2491993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ovulation by prolonged pulsatile administration of luteinizing hormone releasing hormone (LRH) in patients with clomiphene resistant polycystic ovary-like disease.
    Burger CW; van Kessel H; Schoemaker J
    Acta Endocrinol (Copenh); 1983 Nov; 104(3):357-64. PubMed ID: 6415997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary response during pulsatile luteinizing hormone-releasing hormone ovulation--induction in patients with clomiphene citrate-resistant polycystic ovary-like disease.
    Burger CW; Korsen TJ; Schoemaker J
    Gynecol Endocrinol; 1988 Mar; 2(1):19-33. PubMed ID: 3140589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ovulation with pulsatile gonadotropin releasing hormone (GnRH) in anovulatory women.
    Cignitti M; Mazzarini A; Pini A; Garzetti GG; Romanini C
    Acta Eur Fertil; 1990; 21(5):235-8. PubMed ID: 2132474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling.
    Abuelghar WM; Bayoumy HA; Ellaithy MI; Khalil MS
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():178-85. PubMed ID: 24576485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome.
    Kettel LM; Roseff SJ; Berga SL; Mortola JF; Yen SS
    Fertil Steril; 1993 Mar; 59(3):532-8. PubMed ID: 8458453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
    Saffan DS; Seibel MM
    J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease.
    Blankstein J; Rabinovici J; Goldenberg M; Shaley J; Mehta A; Serr DM; Mashiach S
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1164-7. PubMed ID: 3119650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
    Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
    Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
    Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
    Zaidi J; Jacobs H; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy after prolonged pulsatile administration of luteinizing hormone-releasing hormone in a patient with clomiphene-resistant secondary amenorrhea.
    Schoemaker J; Simons AH; van Osnabrugge GJ; Lugtenburg C; van Kessel H
    J Clin Endocrinol Metab; 1981 May; 52(5):882-5. PubMed ID: 6785291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
    Fulghesu AM; Lanzone A; Guida C; Nicoletti MC; Rossi P; Le Donne M; Caruso A; Mancuso S
    J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of chronic anovulation in the polycystic ovary syndrome: normalization of sex-hormone-binding globulin levels after clomiphene-induced ovulation.
    Eden JA; Place J; Carter GD; Alaghband-Zadeh J; Pawson ME
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):323-32. PubMed ID: 2512039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
    Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
    Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
    Saffan D; Seibel MM
    Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsatile luteinizing hormone-releasing hormone therapy in women with polycystic ovary syndrome.
    Eshel A; Abdulwahid NA; Armar NA; Adams JM; Jacobs HS
    Fertil Steril; 1988 Jun; 49(6):956-60. PubMed ID: 3286291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.